Long Term Follow-up of the TREOCAPA Study (TREOCAPA-LT) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Long Term Follow-up of the TREOCAPA Study (TREOCAPA-LT) — Stella

Home/Patency of the Ductus Arteriosus Acetaminophen Extreme Prematurity/

View on ClinicalTrials.gov

Recruiting

Back to Patency of the Ductus Arteriosus Acetaminophen Extreme Prematurity trials

Trial locations(8 sites)

France

CHU d'Angers, Angers

Hôpital Femme Mère Enfant, Bron

CHU de Montpellier, Montpellier

CHU de Nantes, Nantes

Cochin - APHP, Paris

Hopital Robert Debré, Paris

CHU de Strasbourg, Strasbourg

CHU de Tours, Tours

Key details

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Enrollment target

~500 participants

Started

December 2023

Primary completion

December 2026

Age range

23 Months – 27 Months

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.